Manulife (Manufacturers Life Insurance)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.68M Sell
37,202
-24,216
-39% -$3.71M ﹤0.01% 1103
2025
Q4
$8.47M Sell
61,418
-28,422
-32% -$3.72M 0.01% 958
2025
Q3
$11.5M Sell
89,840
-752
-0.8% -$91.8K 0.01% 794
2025
Q2
$11M Buy
90,592
+11
+0% +$1.24K 0.01% 798
2025
Q1
$10.1M Sell
90,581
-6
-0% -$639 0.01% 828
2024
Q4
$8.82M Buy
90,587
+829
+0.9% +$88.4K 0.01% 948
2024
Q3
$10.3M Hold
89,758
0.01% 880
2024
Q2
$9.56M Sell
89,758
-30
-0% -$3.01K 0.01% 856
2024
Q1
$8.69M Sell
89,788
-3,538
-4% -$363K 0.01% 919
2023
Q4
$9.42M Sell
93,326
-756
-0.8% -$73K 0.01% 877
2023
Q3
$9.58M Sell
94,082
-262
-0.3% -$26.6K 0.01% 833
2023
Q2
$9.52M Sell
94,344
-499
-0.5% -$49.9K 0.01% 810
2023
Q1
$8.73M Buy
94,843
+376
+0.4% +$32.8K ﹤0.01% 857
2022
Q4
$8.57M Sell
94,467
-52,580
-36% -$4.43M 0.01% 844
2022
Q3
$11.2M Sell
147,047
-18,044
-11% -$1.5M 0.01% 758
2022
Q2
$14M Sell
165,091
-44,454
-21% -$3.9M 0.01% 707
2022
Q1
$18.4M Buy
209,545
+42,478
+25% +$3.68M 0.01% 690
2021
Q4
$14.6K Hold
167,067
0.01% 777
2021
Q3
$13.7M Buy
167,067
+67,027
+67% +$6.03M 0.01% 799
2021
Q2
$9.13M Sell
100,040
-663,039
-87% -$59M 0.01% 1000
2021
Q1
$65.2M Sell
763,079
-392,176
-34% -$35.2M 0.06% 313
2020
Q4
$109M Sell
1,155,255
-96,746
-8% -$8.45M 0.1% 209
2020
Q3
$109M Sell
1,252,001
-1,967,127
-61% -$170M 0.11% 184
2020
Q2
$281M Sell
3,219,128
-4,635
-0.1% -$400K 0.26% 84
2020
Q1
$266M Buy
3,223,763
+69,706
+2% +$6.22M 0.29% 78
2019
Q4
$299M Buy
3,154,057
+259,993
+9% +$23.3M 0.31% 78
2019
Q3
$253M Buy
2,894,064
+174,586
+6% +$15.7M 0.28% 90
2019
Q2
$248M Sell
2,719,478
-412,054
-13% -$34.9M 0.29% 92
2019
Q1
$237M Sell
3,131,532
-50,291
-2% -$4.04M 0.26% 100
2018
Q4
$245M Buy
3,181,823
+1,071,034
+51% +$83.4M 0.31% 87
2018
Q3
$163M Buy
2,110,789
+237,866
+13% +$17.6M 0.17% 138
2018
Q2
$127M Buy
1,872,923
+548,022
+41% +$37.8M 0.14% 164
2018
Q1
$96M Sell
1,324,901
-364,715
-22% -$27.8M 0.11% 202
2017
Q4
$127M Sell
1,689,616
-3,752,157
-69% -$283M 0.14% 173
2017
Q3
$419M Sell
5,441,773
-178,880
-3% -$13.5M 0.5% 45
2017
Q2
$420M Buy
5,620,653
+168,645
+3% +$12M 0.51% 38
2017
Q1
$363M Sell
5,452,008
-78,295
-1% -$5.22M 0.46% 51
2016
Q4
$361M Buy
5,530,303
+1,222,687
+28% +$79.3M 0.51% 42
2016
Q3
$305M Sell
4,307,616
-120,749
-3% -$8.8M 0.45% 53
2016
Q2
$327M Buy
4,428,365
+472,724
+12% +$32.7M 0.5% 48
2016
Q1
$257M Buy
3,955,641
+979,398
+33% +$66.6M 0.22% 75
2015
Q4
$229K Sell
2,976,243
-139,717
-4% -$11.1M 0.22% 79
2015
Q3
$257K Buy
3,115,960
+57,133
+2% +$5.08M 0.27% 76
2015
Q2
$270K Sell
3,058,827
-11,214
-0.4% -$1.03M 0.32% 63
2015
Q1
$271K Buy
3,070,041
+171,799
+6% +$15.2M 0.34% 58
2014
Q4
$241K Buy
2,898,242
+144,288
+5% +$12M 0.35% 63
2014
Q3
$232K Buy
2,753,954
+93,953
+4% +$7.6M 0.34% 53
2014
Q2
$216M Buy
2,660,001
+156,458
+6% +$12.3M 0.33% 60
2014
Q1
$191K Buy
2,503,543
+124,085
+5% +$9.04M 0.3% 70
2013
Q4
$171K Buy
2,379,458
+72,631
+3% +$5.05M 0.27% 67
2013
Q3
$159K Sell
2,306,827
-604,519
-21% -$40M 0.26% 65
2013
Q2
$184M Buy
+2,911,346
New +$189M 0.35% 51

Other funds holding NVS

Manulife (Manufacturers Life Insurance)'s NVS Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Novartis (NVS) stake by 39% in Q1 2026, selling an estimated $3.71M and leaving 37,202 shares worth $5.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1103.

Manulife (Manufacturers Life Insurance) first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $420M in Q2 2017. 1,596 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 37,202 shares of Novartis worth $5.68M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 24,216 Novartis shares in Q1 2026, an estimated $3.71M.
  • Novartis made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1103 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Novartis position peaked at $420M in Q2 2017.
  • 1,596 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.